An Act to Prohibit the Sale of Tobacco Products in Pharmacies and Retail Establishments Containing Pharmacies
Summary
LD 166 prohibits the sale of tobacco products in pharmacies and in retail establishments that contain a pharmacy. It makes pharmacies ineligible for a retail tobacco license and extends that same ineligibility to stores with an in-store pharmacy. A pharmacy or covered retail establishment that sells, keeps for sale, or gives away tobacco products would commit a civil violation, subject to a fine of up to $2,000 per day of violation.
The bill also makes a technical change to Maine’s cigarette tax stamp provisions, updating the statute governing sales of cigarette stamps to licensed distributors. The bill does not change the cigarette tax rate itself, but it is tied to the broader tobacco retail licensing framework. The act takes effect April 1, 2026, giving affected businesses time to adjust their inventory and sales practices.
Impact
This bill amends Maine’s tobacco licensing laws in Title 22 to bar pharmacies and stores containing pharmacies from obtaining retail tobacco licenses and to create a civil penalty for tobacco sales in those locations. It also makes a conforming amendment in Title 36 to cigarette stamp administration, without altering the underlying cigarette tax. The practical effect is to remove tobacco products from pharmacy-based retail settings and require affected retailers to stop selling tobacco or face daily fines.
Sentiment
The voting history suggests the bill was controversial but ultimately advanced with majority support in both chambers. The close vote margins indicate meaningful opposition, yet the measure was enacted and approved, reflecting enough legislative agreement to move it forward. Overall, the sentiment appears generally favorable among supporters of tobacco-control policy, with a substantial minority resisting the restriction.
Contention
The main point of contention is whether pharmacies and stores with pharmacies should be allowed to sell tobacco products at all. Supporters likely viewed the bill as a public health measure that reduces the visibility and availability of tobacco in healthcare-related settings, while opponents likely objected to limiting lawful retail sales and imposing new compliance burdens on pharmacies and mixed-use retailers. The narrow roll-call votes show that the issue divided legislators, especially around the scope of the ban and its effect on existing retail businesses.